The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema
Open accessAbstract
Lymphedema is a dreaded complication of cancer treatment. However, despite the fact that >5 million Americans are affected by this disorder, the development of effective treatments is limited by the fact that the pathology of lymphedema remains unknown. The purpose of these studies was to determine the role of inflammatory responses in lymphedema pathology. Using mouse models of lymphedema, as well as clinical lymphedema specimens, we show that lymphatic stasis results in a CD4 T-cell inflammation and T-helper 2 (Th2) differentiation. Using mice deficient in T cells or CD4 cells, we show that this inflammatory response is necessary for the pathological changes of lymphedema, including fibrosis, adipose deposition, and lymphatic dysfunction. Further, we show that inhibition of Th2 differentiation using interleukin-4 (IL-4) or IL-13 blockade prevents initiation and progression of lymphedema by decreasing tissue fibrosis and significantly improving lymphatic function, independent of lymphangiogenic growth factors. We show that CD4 inflammation is a critical regulator of tissue fibrosis and lymphatic dysfunction in lymphedema and that inhibition of Th2 differentiation markedly improves lymphatic function independent of lymphangiogenic cytokine expression. Notably, preventing and/or reversing the development of pathological tissue changes that occur in lymphedema may be a viable treatment strategy for this disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CD4+ T cells and cytokine signaling are critical to the regulation of fibrosis and swelling in the mouse tail wound model of lymphedema (140, 141).”
From Transport and Immune Functions of the Lymphatic System. (2025) · cites this paper as [141]
Citations
Cites
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
Neurath, M. F., & Finotto, S. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.02.003 · Cited by 584
Estimating the Population Burden of Lymphedema
Rockson, S. G., & Rivera, K. K. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1413.014 · Cited by 447
Self-citationLymphedema after gynecological cancer treatment
Beesley, V. L., Janda, M., Eakin, E., Obermair, A., & Battistutta, D. (2007) · Cancer · doi:10.1002/cncr.22684 · Cited by 374
Tammela, T., Saaristo, A. M., Holopainen, T., Lyytikkä, J., Kotronen, A., Pitkonen, M., Abo‐Ramadan, U., Ylä‐Herttuala, S., Petrova, T. V., & Alitalo, K. K. (2007) · Nature Medicine · doi:10.1038/nm1689 · Cited by 362
Brennan, M. J., & Miller, L. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981215)83:12b+ · Cited by 244
Self-citationTriggers of IgE class switching and allergy development
Poulsen, L. K., & Hummelshøj, L. (2007) · Annals of Medicine · doi:10.1080/07853890701449354 · Cited by 231
Rutkowski, J. M., Moya, M. L., Johannes, J., Goldman, J., & Swartz, M. A. (2006) · Microvascular Research · doi:10.1016/j.mvr.2006.05.009 · Cited by 229
Inhibition of endogenous TGF-β signaling enhances lymphangiogenesis
Oka, M., Iwata, C., Suzuki, H. I., Kiyono, K., Morishita, Y., Watabe, T., Komuro, A., Kano, M. R., & Miyazono, K. (2008) · Blood · doi:10.1182/blood-2007-10-120337 · Cited by 226
T Lymphocytes Negatively Regulate Lymph Node Lymphatic Vessel Formation
Kataru, R. P., Kim, H., Jang, C., Choi, D. K., Koh, B. I., Kim, M., Gollamudi, S., Kim, Y.-K., Lee, S., & Koh, G. Y. (2011) · Immunity · doi:10.1016/j.immuni.2010.12.016 · Cited by 225
Research works printed but not linked: 1
- 10.1002/(SICI)1097-0142(19981215)83:12B <2776::AID-CNCR25>3.0.CO;2-V · DOI
Cited by
Sorted by citations
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055
Grada, A. A., & Phillips, T. J. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.03.022 · Cited by 481
Lymphatic pumping: mechanics, mechanisms and malfunction
Scallan, J. P., Zawieja, S. D., Castorena‐Gonzalez, J. A., & Davis, M. J. (2016) · The Journal of Physiology · doi:10.1113/jp272088 · Cited by 424
Lymphatic Vessel Network Structure and Physiology
Breslin, J. W., Yang, Y., Scallan, J. P., Sweat, R. S., Adderley, S., & Murfee, W. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c180015 · Cited by 420
The Lymphatic System in Disease Processes and Cancer Progression
Padera, T. P., Meijer, E. F. J., & Munn, L. L. (2016) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-112315-031200 · Cited by 249
Metadata
- Authors
- Avraham, T., Zampell, J. C., Yan, A., Elhadad, S., Weitman, E. S., Rockson, S. G., Bromberg, J., & Mehrara, B. J.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Division of Plastic and Reconstructive Surgery Department of Surgery New York New York USA
- Stanford Medicine (US)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2012-11-27
- Volume
- 27
- Issue
- 3
- Pages
- 1114-1126
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3574290
- OpenAlex
- W2102471792
- Cited by
- 241
- References
- 42
- Citations by year
- 2026: 22 · 2025: 21 · 2024: 19 · 2023: 26 · 2022: 24 · 2021: 24 · 2020: 16 · 2019: 21 · 2018: 12 · 2017: 16 · 2016: 10 · 2015: 12 · 2014: 12 · 2013: 4
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense (BC103691)
- National Heart, Lung, and Blood Institute
- National Institutes of Health (R01HL111130)
- Center for Scientific Review (P30 CA08748)
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
- Keywords
- lymphedema, Th2 differentiation, fibrosis, lymphatic dysfunction, lymphatic stasis, IL-4, IL-13, lymphangiogenesis, cancer treatment complications, lymphedema treatment
- MeSH terms
- Animals, Cell Differentiation, Disease Models, Animal, Fibrosis, Inflammation, Lymphedema, Mice, Nude, Interleukin-4, Mice, Knockout, Th2 Cells, Interleukin-13, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
